“Nanotechnology has the potential to generate enormous health benefits for the more than five billion people living in the developing world,” according to Dr. Peter A. Singer, senior scientist at the McLaughlin-Rotman Centre for Global Health and Professor of Medicine at University of Toronto.
A study funded by the Wellcome Trust and the Sir Halley Stewart Trust has shown that opening windows can be more effective than using mechanical ventilation at reducing the risk of transmission of airborne diseases such as tuberculosis (TB).
In 2005, PLoS Medicine published an essay by John Ioannidis, called “Why most published research findings are false,” that has been downloaded over 100,000 times. This week, PLoS Medicine revisits the essay, publishing two articles by researchers that move the debate in two new directions.
Is it ethical for scientists to conduct or benefit from research in another country if that research would be unlawful, or not generally accepted, in their own country? In a policy paper in PLoS Medicine Loane Skene, Professor of Law at the University of Melbourne, Australia, presents a unique “barometer” for gauging the ethics of such research.
People are more likely to walk when they live in neighborhoods where there are more four-way intersections and a diverse mixture of businesses, according to a RAND Corporation study issued today.
Novartis announced that it has received an “approvable letter” from the US Food and Drug Administration (FDA) for Galvus? (vildagliptin), under review for US approval as a new once-daily oral treatment for patients with type 2 diabetes.
When it comes to lowering cholesterol levels, garlic stinks, according to a new study from the Stanford University School of Medicine.
The gene Sox17 is discovered to play a central role in the complicated dance of signals, enzymes and proteins that transform embryonic stem cells into a beating heart muscle cell.
Three forms of garlic — including raw garlic and two types of commercial garlic supplements — did not significantly reduce low-density lipoprotein (LDL or “bad”) cholesterol during a six-month trial, according to results published in the Feb. 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
New research suggests that gene therapy is a safe treatment method to explore in patients whose lower limbs are at risk for amputation because of poor circulation caused by blocked blood vessels.